Conversion to tacrolimus in hyperlipidemic patients.
Friemann
S
S
Medizinische Klinik II, Justus-Liebig-Universität Giessen, Germany.
Stopp
K
K
Christ
B
B
Weimer
R
R
Padberg
W
W
Ernst
W
W
D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016559:Tacrolimus / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D007166:Immunosuppressive Agents; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D016559:Tacrolimus